IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jake burns who wrote (1293)	3/14/1999 8:37:00 PM
From: Captain Jack	Read Replies (1) of 1510

Looking pretty good at this point!!! Thailand - Interim Analysis by: Country_Doctor 7386 of 7386 trinitygroups.com DSMB/Interim Analysis The first interim analysis meeting for the Remune study in Thailand, Protocol 2101B, was completed on Saturday,13 March 1999. The DSMB reported that the study is going well and has a very high probability of success. The study will continue until completion of all 297 volunteers up to Week 40. In the interim, Dr Vina Churdboonchart, the Principal Investigator will submit an application to the Thai FDA for the registration of Remune in Thailand.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next